Peptide Longevity Q&A ·
Research indicates that Semaglutide induces distinct sex-specific changes in body composition, with male mice experiencing muscle loss while females preserve skeletal muscle. This suggests potential implications for muscle health during weight loss, particularly in older populations.
What the research shows
The study investigated the effects of Semaglutide on skeletal muscle mass, function, and mitochondrial metabolism in leptin-deficient ob/ob mice, which develop severe obesity. Both male and female mice were treated with Semaglutide or a vehicle for three weeks. The research assessed body composition, muscle and organ mass, muscle contractile function, and mitochondrial efficiency. Results demonstrated that while both sexes experienced reductions in body weight and food intake, the effects on body composition differed significantly between males and females.
Why it matters for longevity
The preservation of skeletal muscle is crucial for maintaining functional independence and overall health as individuals age. Muscle loss, or sarcopenia, is a common issue in older adults, often exacerbated by obesity and metabolic disorders. The findings from this research suggest that Semaglutide may offer a therapeutic avenue to mitigate muscle loss during weight loss interventions, particularly in women. Understanding how pharmacological agents like Semaglutide can influence muscle health is vital for developing effective strategies to enhance healthspan and longevity.
Key findings at a glance
- Semaglutide treatment resulted in weight loss in both male and female ob/ob mice.
- Male mice experienced significant losses in skeletal muscle and organ mass.
- Female mice preferentially lost fat and organ mass while preserving skeletal muscle.
- Muscle force generation remained intact in both sexes despite changes in body composition.
- The study highlights the importance of considering biological sex in obesity treatment.
How Semaglutide works (background)
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that enhances insulin secretion, suppresses glucagon release, and slows gastric emptying. These actions contribute to weight loss by reducing appetite and calorie intake. In addition to its effects on glucose metabolism, Semaglutide may influence muscle metabolism and body composition, as indicated by the study's findings on sex-specific responses. The differential effects on muscle and fat mass suggest that Semaglutide may have unique implications for muscle health during weight loss.
Safety, caveats, and what we don't yet know
While the study provides valuable insights into the effects of Semaglutide on muscle preservation, it is important to note that the research was conducted in a specific mouse model (ob/ob mice), which may not fully represent human physiology. Further studies are needed to explore the long-term effects of Semaglutide on muscle health in diverse populations, including older adults and those with varying metabolic conditions. Additionally, the safety profile and potential side effects of Semaglutide in relation to muscle health require further investigation.
Bottom line
Semaglutide appears to induce sex-specific changes in body composition, preserving skeletal muscle in females while causing muscle loss in males. These findings may have implications for muscle health during weight loss interventions, particularly in aging populations.
Related questions
Can Semaglutide improve metabolic health in older adults?
Research suggests that Semaglutide may positively influence metabolic health by promoting weight loss and improving insulin sensitivity, which are critical factors for aging populations.
Does Semaglutide affect muscle function in aging individuals?
While the study highlights muscle preservation in females, further research is needed to determine the broader implications of Semaglutide on muscle function in aging populations.
What are the potential side effects of Semaglutide in older adults?
Potential side effects of Semaglutide can include gastrointestinal issues and hypoglycemia. However, its specific effects on older adults require more research to fully understand.
Source: PubMed · bioRxiv · published 2026-03-05.